Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Haematologica Année : 2022

Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement

Dates et versions

hal-04516008 , version 1 (21-03-2024)

Identifiants

Citer

Charlotte Rigaud, Samuel Abbou, Stephane Ducassou, Mathieu Simonin, Lou Le Mouel, et al.. Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement. Haematologica, 2022, 107 (9), pp.2255-2260. ⟨10.3324/haematol.2021.280081⟩. ⟨hal-04516008⟩
1 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More